1. Home
  2. RGEN vs NYT Comparison

RGEN vs NYT Comparison

Compare RGEN & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • NYT
  • Stock Information
  • Founded
  • RGEN 1981
  • NYT 1851
  • Country
  • RGEN United States
  • NYT United States
  • Employees
  • RGEN N/A
  • NYT N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • NYT Newspapers/Magazines
  • Sector
  • RGEN Health Care
  • NYT Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • NYT Nasdaq
  • Market Cap
  • RGEN 8.2B
  • NYT 9.1B
  • IPO Year
  • RGEN N/A
  • NYT N/A
  • Fundamental
  • Price
  • RGEN $141.78
  • NYT $53.62
  • Analyst Decision
  • RGEN Buy
  • NYT Buy
  • Analyst Count
  • RGEN 10
  • NYT 5
  • Target Price
  • RGEN $188.38
  • NYT $50.60
  • AVG Volume (30 Days)
  • RGEN 934.6K
  • NYT 710.8K
  • Earning Date
  • RGEN 10-29-2024
  • NYT 08-07-2024
  • Dividend Yield
  • RGEN N/A
  • NYT 0.97%
  • EPS Growth
  • RGEN N/A
  • NYT 52.50
  • EPS
  • RGEN N/A
  • NYT 1.62
  • Revenue
  • RGEN $602,354,000.00
  • NYT $2,467,072,000.00
  • Revenue This Year
  • RGEN $0.08
  • NYT $8.54
  • Revenue Next Year
  • RGEN $12.97
  • NYT $6.68
  • P/E Ratio
  • RGEN N/A
  • NYT $33.07
  • Revenue Growth
  • RGEN N/A
  • NYT 5.50
  • 52 Week Low
  • RGEN $110.45
  • NYT $39.73
  • 52 Week High
  • RGEN $211.13
  • NYT $56.49
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 43.50
  • NYT 45.69
  • Support Level
  • RGEN $138.80
  • NYT $52.23
  • Resistance Level
  • RGEN $150.72
  • NYT $54.90
  • Average True Range (ATR)
  • RGEN 4.98
  • NYT 0.79
  • MACD
  • RGEN -0.92
  • NYT -0.26
  • Stochastic Oscillator
  • RGEN 24.50
  • NYT 26.41

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the major source of revenue for both segments is subscription.

Share on Social Networks: